AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| SRI | Quarterly Activities Report | PRICE SENSITIVE | 24/04/18 | |
| SRI | Paterson North New Drill Targets Highlighted | PRICE SENSITIVE | 28/03/18 | |
| SRI | Half Year Accounts | 12/03/18 | ||
| SRI | RIU Explorers Presentation | 21/02/18 | ||
| SRI Quarterly Activities Report | |||
| 24/04/18 | PRICE SENSITIVE | ||
| SRI Paterson North New Drill Targets Highlighted | |||
| 28/03/18 | PRICE SENSITIVE | ||
| SRI Half Year Accounts | |||
| 12/03/18 | |||
| SRI RIU Explorers Presentation | |||
| 21/02/18 | |||
